Antinuclear antibodies by indirect immunofluorescence and solid phase assays
- PMID: 31076390
- DOI: 10.1136/annrheumdis-2019-215443
Antinuclear antibodies by indirect immunofluorescence and solid phase assays
Keywords: autoimmune diseases; systemic lupus erythematosus; systemic sclerosis.
Conflict of interest statement
Competing interests: XB has been a consultant for Inova Diagnostics and Thermo Fisher. MJF has been a consultant for Inova Diagnostics. MM is employed by Inova Diagnostics. Inova Diagnostics provided reagents to perform the study.
Comment in
-
Response to 'Antinuclear antibodies by indirect immunofluorescence and solid phase assays' by Bossuyt et al.Ann Rheum Dis. 2020 Jun;79(6):e66. doi: 10.1136/annrheumdis-2019-215479. Epub 2019 May 10. Ann Rheum Dis. 2020. PMID: 31076389 No abstract available.
Comment on
-
Assay variation in the detection of antinuclear antibodies in the sera of patients with established SLE.Ann Rheum Dis. 2018 Jun;77(6):911-913. doi: 10.1136/annrheumdis-2017-212599. Epub 2018 Feb 9. Ann Rheum Dis. 2018. PMID: 29440000
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
